Is ATAI Worth Buying in 2026?

AtaiBeckley Inc. Common Stock

STOCK PHARMACEUTICAL PREPARATIONS Updated 2026-06-07

Here’s whether AtaiBeckley Inc. Common Stock (ATAI) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Caution.

🟡
Caution

Positives: 50-day MA is rising (+4.42% over 10 days); RSI 48 — healthy momentum range; strong 1-year return of +59.3%. Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); rising volume on a downtrend (distribution, 1.19x avg). Currently 41.5% off its 52-week high. Score: +0/7.

Ready to act on this? 📈 Trade on Webull

ATAI is trading below its 200-day MA ($4.32) — a key warning sign the longer-term trend is under pressure. An RSI of 48.5 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +59.3% compares to +24.4% for SPY (beat the market by 34.9%). The current 41.5% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $15,927 today
vs. S&P 500 (SPY) — same period beat market by 34.9%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

Above 200-day MA ($4.32)
Above 50-day MA ($4.13)
RSI(14) neutral zone (30–70) — currently 48.5
Positive return (+59.3%)
!Within 10% of period high (−41.5%)
Period Range $3.95
$2.00 $6.75
RSI (14) 48.5
0 · OversoldOverbought · 100

Key Metrics

Price$3.95
Period Return+59.3%
Period High$6.75
Period Low$2.00
Drawdown−41.5%
MA-50$4.13
MA-200$4.32
RSI (14)48.5
Avg Volume (30d)4.8M
vs. SPYbeat by 34.9%
Return Rank#325 of 1245

Trade ATAI

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers